\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ patient\\ could\\ recall\\ 2\\ out\\ of\\ 3\\ objects\\ after\\ 5\\ minutes\\ on\\ mini\\ mental\\ status\\ exam\\.\\ \\ she\\ also\\ had\\ a\\ right\\ hemianopsia\\ on\\ physical\\ examination\\.\ \(0\)\
\-\ surgical\\ resection\\ and\\ follow\\-up\\ imaging\ \(0\)\
\-\ 5cm\\ x\\ 4cm\\ x\\ 4\\.4cm\\ cystic\\ intra\\-axial\\ mass\\ with\\ internal\\ septations\\ within\\ the\\ left\\ occipital\\ lobe\\.\\ \\ the\\ mass\\ affects\\ the\\ cortex\\ and\\ causes\\ mass\\ effect\\.\\ \\ \\ the\\ septations\\ show\\ post\\-gadolinium\\ enhancement\\.\\ \\ there\\ is\\ a\\ nodule\\ at\\ the\\ base\\ of\\ the\\ lesion\\ and\\ a\\ curvilinear\\ area\\ at\\ the\\ anterior\\ and\\ superior\\ aspects\\ of\\ the\\ lesion\\ which\\ are\\ hyperintense\\ on\\ pre\\-gadolinium\\ t1\\ images\\ \\-\\ that\\ may\\ represent\\ blood\\ products\\.\\ \\ there\\ is\\ an\\ area\\ of\\ increased\\ flair\\ signal\\ surrounding\\ the\\ lesion\\ that\\ is\\ consistent\\ with\\ intraaxial\\ vasogenic\\ edema\\.\\ \\ there\\ is\\ a\\ 4mm\\ left\\-to\\-right\\ midline\\ shift\\.\\ \\ this\\ lesion\\ also\\ demonstrates\\ increased\\ perfusion\\.\ \(0\)\
\-\ meningeal\\ hemangiopericytoma\ \(0\)\
\-\ \\â\\€\\¢\\ glioblastoma\\ multiforme\ \(0\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ oligodendroglioma\ \(1\)\
\-\ \\â\\€\\¢\\ hemangiopericytoma\ \(1\)\
\-\ \\â\\€\\¢\\ dural\\ metastatsis\\ \\(e\\.g\\.\\ breast\\ ca\\,\\ lymphoma\\)\ \(0\)\
\-\ \\â\\€\\¢\\ sarcoid\ \(3\)\
\-\ \\â\\€\\¢\\ pnet\ \(0\)\
\-\ 35\\ yo\\ woman\\ without\\ significant\\ past\\ medical\\ history\\ who\\ presents\\ with\\ a\\ 2\\ week\\ h\\/o\\ headache\\ and\\ blurry\\ vision\\.\\ \\ episodes\\ of\\ nausea\\/vomiting\\ 3\\ days\\ before\\ presentation\\.\ \(0\)\
\-\ meningeal\\ hemangiopericytomas\\ are\\ rare\\ malignant\\ primary\\ cns\\ neoplasms\\ that\\ arise\\ from\\ the\\ pericytes\\ that\\ surround\\ the\\ endothelial\\ lining\\ of\\ capillaries\\ and\\ venules\\.\\ \\ they\\ make\\ up\\ 2\\.5\\%\\ of\\ meningeal\\ tumors\\ and\\ 1\\%\\ of\\ intracranial\\ tumors\\.\\ the\\ average\\ age\\ at\\ diagnosis\\ is\\ 40\\ years\\ old\\ and\\ these\\ tumors\\ are\\ more\\ common\\ in\\ men\\ than\\ women\\.\\ \\ seventy\\ percent\\ of\\ hemangiopericytomas\\ are\\ supratentorial\\ while\\ 15\\%\\ are\\ found\\ in\\ the\\ posterior\\ fossa\\ and\\ 15\\%\\ percent\\ are\\ spinal\\.\\ \\ patients\\ with\\ supratentorial\\ hemangiopericytomas\\ often\\ present\\ with\\ headache\\ or\\ a\\ focal\\ neurological\\ deficit\\ with\\ only\\ 16\\%\\ presenting\\ with\\ seizures\\.\\ \\ \ \(0\)\
\-\ ct\\ reveals\\ a\\ hyperdense\\ lesion\\ with\\ focal\\ areas\\ of\\ hypodensity\\ and\\ heterogeneous\\ enhancement\\.\\ \\ bone\\ erosion\\ can\\ also\\ be\\ detected\\ on\\ ct\\.\\ \\ mri\\ often\\ shows\\ t1\\ and\\ t2\\ isointensity\\ with\\ flow\\ voids\\.\\ \\ there\\ is\\ also\\ heterogeneous\\ enhancement\\.\\ \\ fifty\\ percent\\ will\\ have\\ a\\ dural\\ tail\\ sign\\.\\ \\ there\\ may\\ be\\ a\\ corkscrew\\ vascular\\ configuration\\.\\ \\ \ \(0\)\
\-\ meningeal\\ hemangiopericytomas\\ are\\ aggressive\\ tumors\\.\\ \\ after\\ gross\\ resection\\,\\ these\\ tumors\\ often\\ recur\\ locally\\,\\ along\\ the\\ neuraxis\\ or\\ outside\\ the\\ cns\\ \\(eg\\ bone\\,\\ lung\\,\\ liver\\)\\ \\ radiation\\ therapy\\ appears\\ to\\ increase\\ disease\\-free\\ survival\\ and\\ overall\\ survival\\.\\ \\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ \\ chheda\\,\\ mg\\.\\ \\ kesari\\,\\ s\\.\\ \\ wen\\,\\ py\\.\\ \\ uptodate\\ version\\ 15\\.2\\.\\ \\ april\\ 11\\,\\ 2007\\.\ \(0\)\
\-\ 2\\.\\ \\ al\\-mefty\\.\\ o\\.\\ \\ meningiomas\\.\\ \\ raven\\ press\\.\\ \\ new\\ york\\.\\ \\ 1991\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hemangiopericytomas\\:\\ 0\\.34408592680622174\ \(0\)\
\-\ meningeal\\:\\ 0\\.2419428786564233\ \(0\)\
\-\ tumors\\:\\ 0\\.1977978716478064\ \(0\)\
\-\ the\\:\\ 0\\.17172798977999115\ \(0\)\
\-\ percent\\:\\ 0\\.15958460324613183\ \(0\)\
\-\ are\\:\\ 0\\.1428752823418159\ \(0\)\
\-\ and\\:\\ 0\\.13337985963593438\ \(0\)\
\-\ lesion\\:\\ 0\\.12893995580986506\ \(0\)\
\-\ supratentorial\\:\\ 0\\.12227258621821692\ \(0\)\
\-\ septations\\:\\ 0\\.11651334798078035\ \(0\)\
\-\ hemangiopericytoma\\:\\ 0\\.1141820938830529\ \(0\)\
\-\ 4cm\\:\\ 0\\.11332471216567624\ \(0\)\
\-\ 15\\:\\ 0\\.10904345685770431\ \(0\)\
\-\ there\\:\\ 0\\.10701382491685686\ \(0\)\
\-\ often\\:\\ 0\\.10529337820498405\ \(0\)\
\-\ of\\:\\ 0\\.10526411265410207\ \(0\)\
\-\ survival\\:\\ 0\\.10499212215832938\ \(0\)\
\-\ also\\:\\ 0\\.10120458186623742\ \(0\)\
\-\ cns\\:\\ 0\\.10046326468780213\ \(0\)\
\-\ dural\\:\\ 0\\.09546646091306311\ \(0\)\
\-\ with\\:\\ 0\\.09479430714269686\ \(0\)\
\-\ that\\:\\ 0\\.09337089529260834\ \(0\)\
\-\ enhancement\\:\\ 0\\.09288128951006358\ \(0\)\
\-\ is\\:\\ 0\\.08838409124106783\ \(0\)\
\-\ metastatsis\\:\\ 0\\.08602148170155544\ \(0\)\
\-\ pericytes\\:\\ 0\\.08602148170155544\ \(0\)\
\-\ chheda\\:\\ 0\\.08602148170155544\ \(0\)\
\-\ wen\\:\\ 0\\.08602148170155544\ \(0\)\
\-\ py\\:\\ 0\\.08602148170155544\ \(0\)\
\-\ venules\\:\\ 0\\.08219811812028774\ \(0\)\
\-\ kesari\\:\\ 0\\.08219811812028774\ \(0\)\
\-\ isointensity\\:\\ 0\\.07948539848843636\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.07786361037581231\ \(0\)\
\-\ version\\:\\ 0\\.07738124967161168\ \(0\)\
\-\ mini\\:\\ 0\\.07566203490716866\ \(0\)\
\-\ neuraxis\\:\\ 0\\.07566203490716866\ \(0\)\
\-\ press\\:\\ 0\\.0742084595353466\ \(0\)\
\-\ headache\\:\\ 0\\.0741606723079273\ \(0\)\
\-\ seventy\\:\\ 0\\.0729493152753173\ \(0\)\
\-\ fifty\\:\\ 0\\.0729493152753173\ \(0\)\
\-\ corkscrew\\:\\ 0\\.07183867132590097\ \(0\)\
\-\ raven\\:\\ 0\\.07183867132590097\ \(0\)\
\-\ capillaries\\:\\ 0\\.06994643198516594\ \(0\)\
\-\ area\\:\\ 0\\.06969152473876541\ \(0\)\
\-\ surround\\:\\ 0\\.06912595169404959\ \(0\)\
\-\ resection\\:\\ 0\\.06895982802403573\ \(0\)\
\-\ recall\\:\\ 0\\.06837118299177344\ \(0\)\
\-\ objects\\:\\ 0\\.06837118299177344\ \(0\)\
\-\ blurry\\:\\ 0\\.06767237632222753\ \(0\)\
\-\ endothelial\\:\\ 0\\.06767237632222753\ \(0\)\
\-\ t1\\:\\ 0\\.06702872095464377\ \(0\)\
\-\ april\\:\\ 0\\.06584156765373018\ \(0\)\
\-\ on\\:\\ 0\\.06498168197777067\ \(0\)\
\-\ focal\\:\\ 0\\.06434916556394438\ \(0\)\
\-\ locally\\:\\ 0\\.06430908324537353\ \(0\)\
\-\ recur\\:\\ 0\\.06341034877204686\ \(0\)\
\-\ 1991\\:\\ 0\\.06341034877204686\ \(0\)\
\-\ hemianopsia\\:\\ 0\\.0629911875501862\ \(0\)\
\-\ meningiomas\\:\\ 0\\.0629911875501862\ \(0\)\
\-\ intraaxial\\:\\ 0\\.06258986848093052\ \(0\)\
\-\ uptodate\\:\\ 0\\.06258986848093052\ \(0\)\
\-\ lining\\:\\ 0\\.06220493442854884\ \(0\)\
\-\ mass\\:\\ 0\\.061638718044353294\ \(0\)\
\-\ 4mm\\:\\ 0\\.06147922453151419\ \(0\)\
\-\ york\\:\\ 0\\.06147922453151419\ \(0\)\
\-\ at\\:\\ 0\\.0609511812478719\ \(0\)\
\-\ these\\:\\ 0\\.06075009936116423\ \(0\)\
\-\ bone\\:\\ 0\\.058698701889932856\ \(0\)\
\-\ hypodensity\\:\\ 0\\.05850814422206048\ \(0\)\
\-\ increased\\:\\ 0\\.058173851995046995\ \(0\)\
\-\ pnet\\:\\ 0\\.05777300003225446\ \(0\)\
\-\ eg\\:\\ 0\\.057312929527840756\ \(0\)\
\-\ products\\:\\ 0\\.05687426555892779\ \(0\)\
\-\ oligodendroglioma\\:\\ 0\\.05645510433706713\ \(0\)\
\-\ multiforme\\:\\ 0\\.05605378526781145\ \(0\)\
\-\ average\\:\\ 0\\.05605378526781145\ \(0\)\
\-\ curvilinear\\:\\ 0\\.05566885121542976\ \(0\)\
\-\ aspects\\:\\ 0\\.05566885121542976\ \(0\)\
\-\ affects\\:\\ 0\\.05511940018552262\ \(0\)\
\-\ voids\\:\\ 0\\.05511940018552262\ \(0\)\
\-\ men\\:\\ 0\\.054770116742103095\ \(0\)\
\-\ 5cm\\:\\ 0\\.05460020989598939\ \(0\)\
\-\ configuration\\:\\ 0\\.054269313669650626\ \(0\)\
\-\ may\\:\\ 0\\.05413737230546214\ \(0\)\
\-\ perfusion\\:\\ 0\\.05394963645098676\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.05364044236273934\ \(0\)\
\-\ up\\:\\ 0\\.05321550102004498\ \(0\)\
\-\ 2007\\:\\ 0\\.05319486774871061\ \(0\)\
\-\ tail\\:\\ 0\\.05305090197766008\ \(0\)\
\-\ vasogenic\\:\\ 0\\.0529091011876404\ \(0\)\
\-\ make\\:\\ 0\\.05223042168654375\ \(0\)\
\-\ after\\:\\ 0\\.052188555567276966\ \(0\)\
\-\ detected\\:\\ 0\\.051597326605838024\ \(0\)\
\-\ minutes\\:\\ 0\\.05088977670447572\ \(0\)\
\-\ deficit\\:\\ 0\\.05088977670447572\ \(0\)\
\-\ sarcoid\\:\\ 0\\.05044595008838293\ \(0\)\
\-\ neoplasms\\:\\ 0\\.05012627286971906\ \(0\)\
\-\ erosion\\:\\ 0\\.049919021123948054\ \(0\)\
\-\ hyperdense\\:\\ 0\\.04951770205469238\ \(0\)\
\-\ overall\\:\\ 0\\.04941998537880624\ \(0\)\
\-\ arise\\:\\ 0\\.04922753839639238\ \(0\)\
\-\ episodes\\:\\ 0\\.049132768002310694\ \(0\)\
\-\ women\\:\\ 0\\.04840705810527605\ \(0\)\
\-\ gross\\:\\ 0\\.04773323045653156\ \(0\)\
\-\ shift\\:\\ 0\\.04725768894809216\ \(0\)\
\-\ mg\\:\\ 0\\.04695348273345399\ \(0\)\
\-\ mental\\:\\ 0\\.046878940251680636\ \(0\)\
\-\ vision\\:\\ 0\\.04658652690356002\ \(0\)\
\-\ aggressive\\:\\ 0\\.04651481876454101\ \(0\)\
\-\ occipital\\:\\ 0\\.04602757367406251\ \(0\)\
\-\ ca\\:\\ 0\\.04589286317105919\ \(0\)\
\-\ flair\\:\\ 0\\.04576005006226487\ \(0\)\
\-\ represent\\:\\ 0\\.044759953391135844\ \(0\)\
\-\ neurological\\:\\ 0\\.04418480106887239\ \(0\)\
\-\ seizures\\:\\ 0\\.04390986687526385\ \(0\)\
\-\ cortex\\:\\ 0\\.04380209913268964\ \(0\)\
\-\ be\\:\\ 0\\.043640682767417976\ \(0\)\
\-\ before\\:\\ 0\\.04348599439932647\ \(0\)\
\-\ intracranial\\:\\ 0\\.04328099556835256\ \(0\)\
\-\ outside\\:\\ 0\\.04318014353920782\ \(0\)\
\-\ increase\\:\\ 0\\.04318014353920782\ \(0\)\
\-\ 35\\:\\ 0\\.043130119152186286\ \(0\)\
\-\ references\\:\\ 0\\.042883902165687174\ \(0\)\
\-\ hyperintense\\:\\ 0\\.04278718772978055\ \(0\)\
\-\ nodule\\:\\ 0\\.0424562915034418\ \(0\)\
\-\ fossa\\:\\ 0\\.042226850139297153\ \(0\)\
\-\ presenting\\:\\ 0\\.042136614284777926\ \(0\)\
\-\ 16\\:\\ 0\\.04191473169846361\ \(0\)\
\-\ ct\\:\\ 0\\.04095650730927787\ \(0\)\
\-\ base\\:\\ 0\\.04091684200194187\ \(0\)\
\-\ reveals\\:\\ 0\\.04091684200194187\ \(0\)\
\-\ causes\\:\\ 0\\.040644629186371975\ \(0\)\
\-\ rare\\:\\ 0\\.04060637528060819\ \(0\)\
\-\ midline\\:\\ 0\\.04045489290904932\ \(0\)\
\-\ meningioma\\:\\ 0\\.04030580561628057\ \(0\)\
\-\ 11\\:\\ 0\\.04026889920972194\ \(0\)\
\-\ 40\\:\\ 0\\.039559574329561274\ \(0\)\
\-\ appears\\:\\ 0\\.03939027759472457\ \(0\)\
\-\ could\\:\\ 0\\.039125570392785844\ \(0\)\
\-\ breast\\:\\ 0\\.03906053858441947\ \(0\)\
\-\ they\\:\\ 0\\.038433758092336796\ \(0\)\
\-\ malignant\\:\\ 0\\.0383432334786548\ \(0\)\
\-\ spinal\\:\\ 0\\.03819426395326113\ \(0\)\
\-\ effect\\:\\ 0\\.03773278594457756\ \(0\)\
\-\ status\\:\\ 0\\.03753778040161663\ \(0\)\
\-\ or\\:\\ 0\\.03742497565007457\ \(0\)\
\-\ sign\\:\\ 0\\.03723926533471263\ \(0\)\
\-\ new\\:\\ 0\\.03721259042346314\ \(0\)\
\-\ liver\\:\\ 0\\.03710663902970287\ \(0\)\
\-\ presentation\\:\\ 0\\.03702794949234399\ \(0\)\
\-\ left\\:\\ 0\\.036697697287391154\ \(0\)\
\-\ areas\\:\\ 0\\.03651949345729386\ \(0\)\
\-\ internal\\:\\ 0\\.03625110451666148\ \(0\)\
\-\ week\\:\\ 0\\.036179214144268126\ \(0\)\
\-\ along\\:\\ 0\\.03603705705737744\ \(0\)\
\-\ surrounding\\:\\ 0\\.03587387121998619\ \(0\)\
\-\ flow\\:\\ 0\\.03582776073769591\ \(0\)\
\-\ right\\:\\ 0\\.03566703943253279\ \(0\)\
\-\ radiation\\:\\ 0\\.0356455410608816\ \(0\)\
\-\ vascular\\:\\ 0\\.0355111505461654\ \(0\)\
\-\ out\\:\\ 0\\.03535674470119031\ \(0\)\
\-\ past\\:\\ 0\\.035013031941017354\ \(0\)\
\-\ superior\\:\\ 0\\.03497093555485984\ \(0\)\
\-\ found\\:\\ 0\\.034804404518704646\ \(0\)\
\-\ while\\:\\ 0\\.03476322727056986\ \(0\)\
\-\ will\\:\\ 0\\.034620506656637004\ \(0\)\
\-\ examination\\:\\ 0\\.034420295848164126\ \(0\)\
\-\ medical\\:\\ 0\\.034185522521854014\ \(0\)\
\-\ show\\:\\ 0\\.034146955699836785\ \(0\)\
\-\ days\\:\\ 0\\.03405122315332955\ \(0\)\
\-\ age\\:\\ 0\\.03376972240316149\ \(0\)\
\-\ yo\\:\\ 0\\.03360476936585014\ \(0\)\
\-\ only\\:\\ 0\\.03360476936585014\ \(0\)\
\-\ primary\\:\\ 0\\.03307487857243768\ \(0\)\
\-\ years\\:\\ 0\\.03297238218461087\ \(0\)\
\-\ lung\\:\\ 0\\.032720911952940565\ \(0\)\
\-\ cystic\\:\\ 0\\.03239572197478708\ \(0\)\
\-\ edema\\:\\ 0\\.03208137370502932\ \(0\)\
\-\ lymphoma\\:\\ 0\\.032035112411072784\ \(0\)\
\-\ she\\:\\ 0\\.03201974227753379\ \(0\)\
\-\ shows\\:\\ 0\\.03156991574462015\ \(0\)\
\-\ blood\\:\\ 0\\.03123901951828139\ \(0\)\
\-\ lobe\\:\\ 0\\.031084777680458905\ \(0\)\
\-\ significant\\:\\ 0\\.031057002771310127\ \(0\)\
\-\ t2\\:\\ 0\\.03094671408905016\ \(0\)\
\-\ therapy\\:\\ 0\\.030905686142504545\ \(0\)\
\-\ common\\:\\ 0\\.030504935685112543\ \(0\)\
\-\ signal\\:\\ 0\\.03049186627922492\ \(0\)\
\-\ than\\:\\ 0\\.03049186627922492\ \(0\)\
\-\ who\\:\\ 0\\.03042678959002733\ \(0\)\
\-\ patients\\:\\ 0\\.0302596625527595\ \(0\)\
\-\ anterior\\:\\ 0\\.030033039699994525\ \(0\)\
\-\ more\\:\\ 0\\.02953631270450163\ \(0\)\
\-\ physical\\:\\ 0\\.02916602415319726\ \(0\)\
\-\ consistent\\:\\ 0\\.02916602415319726\ \(0\)\
\-\ without\\:\\ 0\\.028372058048607533\ \(0\)\
\-\ imaging\\:\\ 0\\.02826832130558557\ \(0\)\
\-\ can\\:\\ 0\\.028227144057450786\ \(0\)\
\-\ woman\\:\\ 0\\.028013865098410726\ \(0\)\
\-\ diagnosis\\:\\ 0\\.027884212635045057\ \(0\)\
\-\ posterior\\:\\ 0\\.027815131191727703\ \(0\)\
\-\ mri\\:\\ 0\\.027610872486717713\ \(0\)\
\-\ present\\:\\ 0\\.027601255377430852\ \(0\)\
\-\ exam\\:\\ 0\\.0270777749002669\ \(0\)\
\-\ demonstrates\\:\\ 0\\.02702337335607622\ \(0\)\
\-\ to\\:\\ 0\\.026894651609737877\ \(0\)\
\-\ have\\:\\ 0\\.02687091851622164\ \(0\)\
\-\ had\\:\\ 0\\.026800019123276148\ \(0\)\
\-\ in\\:\\ 0\\.026762276190215484\ \(0\)\
\-\ surgical\\:\\ 0\\.0261435613880118\ \(0\)\
\-\ presents\\:\\ 0\\.025875634651574077\ \(0\)\
\-\ images\\:\\ 0\\.024881329344893694\ \(0\)\
\-\ within\\:\\ 0\\.024773889046536494\ \(0\)\
\-\ which\\:\\ 0\\.024458723529446447\ \(0\)\
\-\ from\\:\\ 0\\.021362998662597173\ \(0\)\
\-\ an\\:\\ 0\\.02056901060969924\ \(0\)\
\-\ history\\:\\ 0\\.020550789203375355\ \(0\)\
\-\ this\\:\\ 0\\.018483118477838692\ \(0\)\
\-\ patient\\:\\ 0\\.017495097515695918\ \(0\)\
\-\ old\\:\\ 0\\.015919595348770015\ \(0\)\
